feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

IBPS RRB Admit Card Released

trending

Verstappen wins, Abu Dhabi finale

trending

Sri Lanka cyclone death toll

trending

Aequs IPO opens December 3

trending

Bajaj Finance shares tumble

trending

RIL share price reaches high

trending

Silver price hits all-time high

trending

Lenskart share price jumps

trending

MCX gold price rises

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / New Glasses Slow Kids' Nearsightedness

New Glasses Slow Kids' Nearsightedness

1 Dec

•

Summary

  • New FDA-approved lenses slow myopia progression in children.
  • Specialized lenses use ringed dots to refocus light on the retina.
  • The new glasses are expected to cost $450 and are insurance-covered.

The FDA has approved a novel lens technology designed to slow the progression of myopia, or nearsightedness, in children aged 6 to 12. This innovative approach, previously available internationally, is now rolling out in the United States. The Essilor Stellest lenses feature 11 concentric rings with tiny dots, engineered to redirect light onto the retina in a way that may inhibit eye elongation.

Studies submitted to the FDA indicated significant results, with children experiencing a 70% reduction in myopia progression and a 50% decrease in eye lengthening over a two-year period. Experts believe this technology could prevent long-term complications associated with severe myopia, such as retinal detachment and glaucoma, potentially safeguarding vision into adulthood.

While the suggested retail price is $450, major U.S. vision insurance providers are expected to cover the cost for eligible children. This new option offers an alternative to existing treatments like MiSight contact lenses or off-label medicated eye drops, addressing potential parental hesitancy regarding contact lenses for younger children.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Myopia, or nearsightedness, makes distant objects blurry. Its increase is linked to more indoor screen time and close-up activities.
These lenses use 11 concentric rings with tiny dots to refocus light on the retina, aiming to slow eye elongation.
The glasses offer an alternative for parents hesitant about putting younger children in contact lenses.

Read more news on

Healthside-arrow

You may also like

Undeclared Allergens Spark Nationwide Food Recall Wave

19 hours ago • 6 reads

article image

Zydus Lifesciences Secures FDA Tentative Approval for Diabetes Drug

27 Nov • 28 reads

article image

Bayer Stroke Drug Trial Shows Promise

24 Nov • 39 reads

article image

Experts Criticize FDA for Baseless Hormone Therapy Claims

24 Nov • 32 reads

article image

Supplements Hide Deadly Drugs

19 Nov • 57 reads

article image